Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lh3
    Senior Member
    • Feb 2008
    • 686

    #16
    Another way to check if you have the reference genome. Map your reads to the reference genome, collect reads mapped to the forward strand and in coding regions, and count the number of reads starting at phase 1, 2 and 3 separately. If my hypothesis is correct, the 3 numbers will be statistically different and correlated with the GC% at the 3 phases.

    Comment

    • greigite
      Senior Member
      • Mar 2009
      • 145

      #17
      Originally posted by lh3 View Post
      Another way to check if you have the reference genome. Map your reads to the reference genome, collect reads mapped to the forward strand and in coding regions, and count the number of reads starting at phase 1, 2 and 3 separately. If my hypothesis is correct, the 3 numbers will be statistically different and correlated with the GC% at the 3 phases.
      Great suggestion. Unfortunately, my libraries are metagenomes- so no reference is available. I hope someone else will be able to do this analysis and post the results!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Yesterday, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      71 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...